La Notte dei Ricercatori, parte del progetto europeo Sharper, è un appuntamento annuale che mira a connettere la comunità scientifica con il grande pubblico, promuovendo l’innovazione e la ricerca. Organizzata in diverse città italiane, l’edizione catanese ha offerto come uno dei momenti più significativi la tavola rotonda intitolata “AI, Robotica, Quantum Technologies: le sfide che ci portano nel…
Read more
Yesterday morning in Rome, the ANNUAL MEETING 2024 of the 💻 #ICSC – National Research Center in #HPC, #BigData, and #QuantumComputing successfully concluded. This highly anticipated event, held over four days, gathered the entire community of the National Center for the first time, creating a platform for meaningful discussions and collaborations. Among the many topics covered during the event,…
Read more
The In Silico World final event at the VPH2024 conference in Stuttgart marked a pivotal moment in the journey of in silico medicine, and the Combine group was proud to be an integral part of this milestone. With over 180 participants, both in-person and remote, the event was a unique opportunity to reflect on the…
Read more
We are pleased to share a remarkable achievement within our ongoing research efforts. Our team has made a significant contribution to an innovative project funded by the European Food Safety Authority (EFSA), which is focused on reducing the reliance on in vivo experiments through the adoption of Non-Animal Methods (NAMs). This collaborative endeavor has culminated…
Read more
L’ 11 luglio 2024, l’Università degli Studi di Catania (UNICT) ha ospitato l’evento 🌟 𝐏𝐢𝐚𝐜𝐞𝐫𝐢 𝐃𝐚𝐲 𝟐𝟎𝟐𝟒 🌟, una giornata dedicata all’innovazione e alla ricerca scientifica. Siamo lieti di annunciare che Combine Group ha avuto l’opportunità di partecipare a questo prestigioso evento, dimostrando il valore e l’impatto del nostro lavoro. Un Palcoscenico per l’Innovazione La…
Read more
Drug development, testing, and approval are intricate processes that typically take 10 to 15 years and cost millions of euros. Most of this time and money are invested in clinical trials, which are essential for proving the drug’s safety and effectiveness. But have you ever wondered if this process could be made faster, cheaper, and…
Read more
3 maggio 2024 📍 Conference Center Four Points by Sheraton Catania Hotel Incontro scientifico “𝑷𝒓𝒆𝒗𝒆𝒏𝒛𝒊𝒐𝒏𝒆 𝒆 𝒄𝒖𝒓𝒂 𝒅𝒆𝒊 𝒕𝒖𝒎𝒐𝒓𝒊 𝒏𝒆𝒍𝒍’𝒆𝒓𝒂 𝒅𝒆𝒍𝒍’𝒊𝒏𝒕𝒆𝒍𝒍𝒊𝒈𝒆𝒏𝒛𝒂 𝒂𝒓𝒕𝒊𝒇𝒊𝒄𝒊𝒂𝒍𝒆” Durante l’incontro scientifico che si è tenuto oggi al Conference Center Four Points by Sheraton Catania Hotel, il Prof. Francesco Pappalardo ha presentato un’intervento di grande interesse dal titolo “𝙌𝙪𝙖𝙣𝙙𝙤 𝙞 𝙢𝙤𝙙𝙚𝙡𝙡𝙞 𝙘𝙤𝙢𝙥𝙪𝙩𝙖𝙯𝙞𝙤𝙣𝙖𝙡𝙞…
Read more
Don’t miss out on Professor Francesco Pappalardo’s interview discussing the study on the #JollyVaccine!
We’re thrilled to announce that our research team at the University of Catania is on the front page of #UnictMagazine with a groundbreaking new study on the #JollyVaccine! In this pioneering study, we’ve worked tirelessly to develop an innovative solution to address the challenges associated with vaccination, focusing on the concept of a “Jolly Vaccine.”…
Read more
Article: ‘Sviluppare un vaccino influenzale universale simulanndo gli anticorpi’ In the latest edition of #LaSicilia, a groundbreaking study has been highlighted, shedding light on the development of a universal influenza vaccine through the simulation of antibodies. Conducted by the esteemed research team led by Prof. Francesco Pappalardo at the #CombineGroup, this study has immense implications…
Read more